BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12151172)

  • 1. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis.
    Peterson GM
    Obstet Gynecol; 2002 Aug; 100(2):381; author reply 381-2. PubMed ID: 12151172
    [No Abstract]   [Full Text] [Related]  

  • 2. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis.
    Soller RW
    Obstet Gynecol; 2002 Aug; 100(2):380-1. PubMed ID: 12151171
    [No Abstract]   [Full Text] [Related]  

  • 3. Vulvo-vaginal candidiasis.
    Medlen L
    Nurs RSA; 1987; 2(11-12):35. PubMed ID: 3444468
    [No Abstract]   [Full Text] [Related]  

  • 4. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis.
    Ferris DG; Nyirjesy P; Sobel JD; Soper D; Pavletic A; Litaker MS
    Obstet Gynecol; 2002 Mar; 99(3):419-25. PubMed ID: 11864668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of maintenance therapy with topical boric acid in comparison with oral itraconazole in the treatment of recurrent vulvovaginal candidiasis.
    Guaschino S; De Seta F; Sartore A; Ricci G; De Santo D; Piccoli M; Alberico S
    Am J Obstet Gynecol; 2001 Mar; 184(4):598-602. PubMed ID: 11262459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Problems with over-the-counter vaginal preparations.
    Kabongo ML
    Am Fam Physician; 1993 Sep; 48(4):579. PubMed ID: 8379485
    [No Abstract]   [Full Text] [Related]  

  • 7. [Contribution to the therapy of vulvuovaginal mycoses (author's transl)].
    Wenzel-Heiniger K
    Schweiz Rundsch Med Prax; 1976 Mar; 65(10):287-8. PubMed ID: 1257188
    [No Abstract]   [Full Text] [Related]  

  • 8. The development of evidence-based guidelines for over-the-counter treatment of vulvovaginal candidiasis.
    Bond CM; Watson MC;
    Pharm World Sci; 2003 Aug; 25(4):177-81. PubMed ID: 12964498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal vaginal discharge: what does and does not work in treating underlying causes.
    French L; Horton J; Matousek M
    J Fam Pract; 2004 Nov; 53(11):890-4. PubMed ID: 15527726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Summary of the national seminar on diagnosis and treatment of female vulvar-vaginal diseases].
    Jiang L; Wang JL; Zhu L
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jul; 43(7):483-5. PubMed ID: 19080507
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic principles in vulvovaginal dermatology.
    Beecker J
    Dermatol Clin; 2010 Oct; 28(4):639-48. PubMed ID: 20883909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in prescribing for vulvovaginal candidiasis in the United States.
    McCaig LF; McNeil MM
    Pharmacoepidemiol Drug Saf; 2005 Feb; 14(2):113-20. PubMed ID: 15386715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gynecologists warn against over-the-counter antifungal agents. Uncontrolled use can worsen vulvovaginal problems].
    Rylander E; Strand A
    Lakartidningen; 1998 Jan; 95(3):134-5. PubMed ID: 9467277
    [No Abstract]   [Full Text] [Related]  

  • 14. Improving appropriate use of antifungal medications: the role of an over-the-counter vaginal pH self-test device.
    Roy S; Caillouette JC; Faden JS; Roy T; Ramos DE
    Infect Dis Obstet Gynecol; 2003; 11(4):209-16. PubMed ID: 15108867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of erosive vulvovaginal lichen planus with methotrexate.
    Jang N; Fischer G
    Australas J Dermatol; 2008 Nov; 49(4):216-9. PubMed ID: 18855784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vulvovaginal lichen planus treatment: a survey of current practices.
    Cooper SM; Haefner HK; Abrahams-Gessel S; Margesson LJ
    Arch Dermatol; 2008 Nov; 144(11):1520-1. PubMed ID: 19015433
    [No Abstract]   [Full Text] [Related]  

  • 17. Depo-Provera in the treatment of recurrent vulvovaginal candidiasis.
    Dennerstein GJ
    J Reprod Med; 1986 Sep; 31(9):801-3. PubMed ID: 2945926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-medication with vaginal antifungal drugs: physicians' experiences and women's utilization patterns.
    Sihvo S; Ahonen R; Mikander H; Hemminki E
    Fam Pract; 2000 Apr; 17(2):145-9. PubMed ID: 10758077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: 2. Factors that may have influenced the marked changes in sales volumes during the 1990s.
    Mårdh PA; Wågström J; Landgren M; Holmén J
    Infect Dis Obstet Gynecol; 2004 Jun; 12(2):99-108. PubMed ID: 15739824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerance of local treatment of acute vulvovaginal candidiasis with 4 different single doses (10, 25, 50 and 100 mg) of Ro 14-4767 versus a 7-day treatment with miconazole.
    Hubert T; Van Bulck B; Van Waes A; Van de Velde E; Van der Pas H; Lambin A
    J Chemother; 1989 Jul; 1(4 Suppl):933-5. PubMed ID: 16312711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.